drugset / Trial / NCT03694587

pK of a Novel 200 mg Ibuprofen Medicated Plaster

NCT03694587

RandomizedCrossoverOpen-labelTreatment

Summary

This is a Phase I study of the pharmacokinetics of a novel 200 mg Ibuprofen Medicated Plaster. The study will be conducted as a monocentric, open, randomised, single and multiple-dose, two-period, crossover trial in healthy volunteers. A total of 16 healthy volunteers will be randomised. A wash-out period of 3 days is planned between the two periods. Each of the volunteers will be randomly assigned to one of 2 possible administration sequences.

Timeline

Start
2018-09-25
Primary completion
2018-10-18
Completion
2018-10-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 200 mg Topical

Indications

No indication recorded.